Evidence map›Paper›PMID 42240263›Full record

ArticleJACC. Case reports2026

Severe Mitral Regurgitation Triggered by Myocardial Ischemia in Hypertrophic Cardiomyopathy With Abnormalities of the Mitral Valve Complex.

Terumori Satoh, Atsushi Sakamoto, Kyoko Unno, Kenichiro Suwa, Hiroe Tsukui, Rika Kawakami, Keitaro Akita, Hayato Ohtani, Kazuma Okamoto, Yuichiro Maekawa

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Terumori SatohDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Atsushi SakamotoDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan. Electronic address: asakamo@hama-med.ac.jp.
Kyoko UnnoDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kenichiro SuwaDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Hiroe TsukuiDepartment of Diagnostic Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Rika KawakamiCVPath Institute, Gaithersburg, Maryland, USA.
Keitaro AkitaDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Hayato OhtaniDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kazuma OkamotoDivision of Cardiovascular Surgery, Department of Surgery I, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Yuichiro MaekawaDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMitral regurgitation (MR) is a common complication of hypertrophic cardiomyopathy. Clarifying the etiology is essential for its management. CASE SUMMARY: A 73-year-old man with hypertrophic obstructive cardiomyopathy with subsequent alcohol septal ablation presented with worsening dyspnea. Echocardiography revealed severe MR without systolic anterior motion. Imaging revealed that structural abnormalities of the mitral valve complex-including anterior displacement of the papillary muscle, abnormal chordal attachments, and leaflet degeneration-contributed to the MR severity. Coronary angiography revealed a silent occlusion of the right coronary artery. Ischemia-induced left ventricular hypokinesis with leaflet tethering is a critical functional contributor to MR. The patient underwent mitral valve replacement and coronary bypass grafting. Histopathological examination confirmed leaflet degeneration, shortened and thickened chordae tendineae, and ischemic injury to the papillary muscle, supporting multifactorial mechanisms of MR. DISCUSSION: MR in hypertrophic cardiomyopathy arises from combined structural and functional mechanisms, hence comprehensive multimodal evaluations are required for optimal treatment decisions.

Indexed as

coronary artery diseasehypertrophic obstructive cardiomyopathymitral regurgitation

Identifiers

PMID42240263
PMCPMC13244022

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.